Arax Advisory Partners’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $254K | Sell |
5,248
-844
| -14% | -$40.8K | 0.01% | 574 |
|
|
2025
Q1 | $338K | Buy |
6,092
+5,607
| +1,156% | +$311K | 0.02% | 393 |
|
|
2024
Q4 | $23.4K | Sell |
485
-231
| -32% | -$11.1K | ﹤0.01% | 1149 |
|
|
2024
Q3 | $41.3K | Buy |
716
+13
| +2% | +$749 | ﹤0.01% | 792 |
|
|
2024
Q2 | $34.1K | Sell |
703
-22
| -3% | -$1.07K | ﹤0.01% | 791 |
|
|
2024
Q1 | $35.2K | Buy |
725
+154
| +27% | +$7.49K | ﹤0.01% | 561 |
|
|
2023
Q4 | $28.4K | Sell |
571
-47
| -8% | -$2.34K | ﹤0.01% | 597 |
|
|
2023
Q3 | $33.2K | Buy |
618
+26
| +4% | +$1.4K | ﹤0.01% | 514 |
|
|
2023
Q2 | $31.9K | Buy |
592
+129
| +28% | +$6.95K | ﹤0.01% | 521 |
|
|
2023
Q1 | $25.2K | Buy |
463
+344
| +289% | +$18.7K | ﹤0.01% | 548 |
|
|
2022
Q4 | $5.76K | Hold |
119
| – | – | ﹤0.01% | 754 |
|
|
2022
Q3 | $5K | Sell |
119
-55
| -32% | -$2.31K | ﹤0.01% | 821 |
|
|
2022
Q2 | $9K | Buy |
174
+87
| +100% | +$4.5K | ﹤0.01% | 672 |
|
|
2022
Q1 | $4K | Buy |
87
+54
| +164% | +$2.48K | ﹤0.01% | 845 |
|
|
2021
Q4 | $2K | Buy |
+33
| New | +$2K | ﹤0.01% | 929 |
|
|
2021
Q3 | – | Sell |
-45
| Closed | -$2K | – | 1067 |
|
|
2021
Q2 | $2K | Buy |
+45
| New | +$2K | ﹤0.01% | 861 |
|
|
2020
Q4 | $41K | Buy |
836
+54
| +7% | +$2.65K | 0.01% | 437 |
|
|
2020
Q3 | $39K | Sell |
782
-42
| -5% | -$2.1K | 0.01% | 416 |
|
|
2020
Q2 | $42K | Buy |
824
+264
| +47% | +$13.5K | 0.01% | 391 |
|
|
2020
Q1 | $24K | Buy |
560
+143
| +34% | +$6.13K | 0.01% | 441 |
|
|
2019
Q4 | $21K | Buy |
+417
| New | +$21K | 0.01% | 415 |
|
|
2018
Q4 | $8K | Hold |
181
| – | – | ﹤0.01% | 457 |
|
|
2018
Q3 | $8K | Buy |
+181
| New | +$8K | ﹤0.01% | 493 |
|